Paravasthu Mukund's Form 4 filing
NovoCure Ltd (NVCR) · filed Nov 6, 2024
- Accession no.
- 0001562180-24-007567
- Filed
- Nov 6, 2024
- Trade date
- Nov 2-4, 2024
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $734.36. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paravasthu MukundCIK 0002039078 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2024 | Ordinary Shares | SSaleDisposed | −44 | $16.69 | −$734.36 | 3,459 | Direct | |
| Nov 4, 2024 | Ordinary Shares | AGrant or awardAcquired | +30,138 | $0.00 | $0 | 33,597 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2024 | Ordinary Shares | AGrant or awardAcquired | +45,620 | $16.59 | +$756,835.8 | 45,620 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.